Quest Diagnostics Earnings Beat After March Rebound In Demand From Slump Early In The Quarter -- MarketWatch

Dow Jones

Apr 22, 2025

Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow.

Secaucus, N.J.-based Quest $(DGX)$ had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus.

Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. "Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access," he said in prepared remarks.

The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80.

(This is a breaking news story. Check back for updates)

-Ciara Linnane

For more from MarketWatch: http://www.marketwatch.com/newsviewer

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

April 22, 2025 07:01 ET (11:01 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2529743433"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2529743433\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2529743433?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-22 19:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2529743433","market":"sh","top_or_hot":-1,"title":"Quest Diagnostics Earnings Beat After March Rebound In Demand From Slump Early In The Quarter -- MarketWatch","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company  posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow. \n</p>\n<p>\n     Secaucus, N.J.-based Quest <a href=\"https://laohu8.com/S/DGX\">$(DGX)$</a> had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus. \n</p>\n<p>\n     Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. \"Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access,\" he said in prepared remarks. \n</p>\n<p>\n     The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80. \n</p>\n<p>\n     (This is a breaking news story. Check back for updates) \n</p>\n<p>\n     -Ciara Linnane \n</p>\n<p>\n  For more from MarketWatch: http://www.marketwatch.com/newsviewer \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 22, 2025 07:01 ET (11:01 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Quest Diagnostics Earnings Beat After March Rebound In Demand From Slump Early In The Quarter -- MarketWatch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuest Diagnostics Earnings Beat After March Rebound In Demand From Slump Early In The Quarter -- MarketWatch\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-22 19:01</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company  posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow. \n</p>\n<p>\n     Secaucus, N.J.-based Quest <a href=\"https://laohu8.com/S/DGX\">$(DGX)$</a> had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus. \n</p>\n<p>\n     Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. \"Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access,\" he said in prepared remarks. \n</p>\n<p>\n     The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80. \n</p>\n<p>\n     (This is a breaking news story. Check back for updates) \n</p>\n<p>\n     -Ciara Linnane \n</p>\n<p>\n  For more from MarketWatch: http://www.marketwatch.com/newsviewer \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 22, 2025 07:01 ET (11:01 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DGX","symbol_name":"奎斯特诊疗","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2529743433","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2529743433","pubTimestamp":1745319660,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company  posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow.Secaucus, N.J.-based Quest  had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus.Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. \"Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access,\" he said in prepared remarks.The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80.This content was created by MarketWatch, which is opera","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"DGX":"奎斯特诊疗"},"translate_title":"Quest Diagnostics的盈利在3月份需求从季度初的低迷中反弹后超出预期——MarketWatch","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DGX":1},"content_text":"Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company  posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow. \n\n\n     Secaucus, N.J.-based Quest $(DGX)$ had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus. \n\n\n     Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. \"Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access,\" he said in prepared remarks. \n\n\n     The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80. \n\n\n     (This is a breaking news story. Check back for updates) \n\n\n     -Ciara Linnane \n\n\n  For more from MarketWatch: http://www.marketwatch.com/newsviewer \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 22, 2025 07:01 ET (11:01 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}